How many years can apalutamide (Ansenko) be taken and its safety analysis

Apalutamide (Apalutamide) is a non-steroidal anti-androgen drug, mainly used to treat castration-resistant prostate cancer (nmCRPC) and advanced prostate cancer. Clinically, the administration time of apalutamide is usually adjusted according to the patient's condition and tolerance, and there is no clear "maximum period of administration". In some clinical trials, patients can continue taking the drug for several years until disease progression or intolerable side effects occur.

Multiple studies have shown that apalutamide is generally well tolerated when taken long-term. Common side effects include fatigue, rash, thyroid dysfunction, increased risk of fractures, and mild increases in cardiovascular events. Long-term observation shows that most side effects can be effectively managed through dose adjustment, symptomatic treatment, or regular monitoring.

To ensure the safety of long-term medication, patients need to undergo regular hematology tests, liver and kidney function assessment, and bone density monitoring while taking apalutamide. In addition, you should pay attention to cardiovascular health and deal with potential problems such as high blood pressure and arrhythmia in a timely manner. Doctors can adjust the dosage according to individual patient conditions to extend the medication time while maintaining safety.

Generally speaking, apalutamide can be taken for a long time, but the specific number of years needs to be evaluated individually and determined based on the patient's tolerance and disease progression. Proper monitoring and side effect management can reduce the risk of long-term medication, allowing patients to maintain medication safety while maintaining efficacy. Therefore, it is clinically recommended to take it for a long time under the guidance of a professional doctor and adjust the treatment plan at any time according to the condition.

Reference materials:https://www.drugs.com/